Found: 51
Select item for more details and to access through your institution.
NK cells produce high levels of IL‐10 early after allogeneic stem cell transplantation and suppress development of acute GVHD.
- Published in:
- European Journal of Immunology, 2018, v. 48, n. 2, p. 316, doi. 10.1002/eji.201747134
- By:
- Publication type:
- Article
Enhanced Recovery after Renal Transplantation Decreases Recipients' Urological Complications and Hospital Stay: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2286, doi. 10.3390/jcm10112286
- By:
- Publication type:
- Article
Feasibility, Safety and Efficacy of Enhanced Recovery after Living Donor Nephrectomy: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 1, p. 21, doi. 10.3390/jcm10010021
- By:
- Publication type:
- Article
CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.935949
- By:
- Publication type:
- Article
The BMT Data Book: A Manual for Bone Marrow and Blood Stem Cell Transplantation.
- Published in:
- 1998
- By:
- Publication type:
- Book Review
Corticosteroid-Induced Lymphopenia, Immunosuppression, and Body Defense.
- Published in:
- Annals of Internal Medicine, 1978, v. 88, n. 4, p. 564, doi. 10.7326/0003-4819-88-4-564
- By:
- Publication type:
- Article
Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2173, doi. 10.1111/bjh.19463
- By:
- Publication type:
- Article
Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high‐risk acute myeloid leukaemia ineligible for intensive chemotherapy.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 368, doi. 10.1111/bjh.17823
- By:
- Publication type:
- Article
Bone marrow transplantation in the United Kingdom – past, present and future.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 4, p. 612, doi. 10.1111/bjh.17151
- By:
- Publication type:
- Article
Acute myeloid leukaemia therapeutic innovation and clinical trials: past, present and future.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 4, p. 568, doi. 10.1111/bjh.17146
- By:
- Publication type:
- Article
Characteristics of graft‐versus‐host disease occurring after alemtuzumab‐containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 4, p. 550, doi. 10.1111/bjh.16200
- By:
- Publication type:
- Article
The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 1, p. 129, doi. 10.1111/bjh.16355
- By:
- Publication type:
- Article
Impact of graft‐versus‐lymphoma effect on outcomes after reduced intensity conditioned‐alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 547, doi. 10.1111/bjh.15685
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 5, p. 759, doi. 10.1111/bjh.14619
- By:
- Publication type:
- Article
Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and Eurocord.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 3, p. 478, doi. 10.1111/bjh.13913
- By:
- Publication type:
- Article
Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 4, p. 487, doi. 10.1111/bjh.13554
- By:
- Publication type:
- Article
Wilms' Tumour 1 ( WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 3, p. 366, doi. 10.1111/bjh.12637
- By:
- Publication type:
- Article
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3‐ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 274, doi. 10.1002/ajh.26442
- By:
- Publication type:
- Article
Diseases of Cellular Immunity.
- Published in:
- Annals of Internal Medicine, 1972, v. 77, n. 1, p. 101, doi. 10.7326/0003-4819-77-1-101
- By:
- Publication type:
- Article
The immune system, immunoglobulins, and some disorders of the lymphatic system.
- Published in:
- 1966
- By:
- Publication type:
- journal article
Agnogenic Myeloid Metaplasia.
- Published in:
- Annals of Internal Medicine, 1962, v. 57, n. 3, p. 419, doi. 10.7326/0003-4819-57-3-419
- By:
- Publication type:
- Article
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 543, doi. 10.1007/s00262-022-03268-4
- By:
- Publication type:
- Article
Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.666091
- By:
- Publication type:
- Article
Cross-intolerance to imatinib, dasatinib and nilotinib therapy in a patient with chronic myeloid leukaemia.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 6, p. 548, doi. 10.1111/j.1600-0609.2011.01603.x
- By:
- Publication type:
- Article
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.659595
- By:
- Publication type:
- Article
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation
- Published in:
- Clinical Infectious Diseases, 2018, v. 67, n. 4, p. 564, doi. 10.1093/cid/ciy150
- By:
- Publication type:
- Article
Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-example.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 4, p. 369, doi. 10.1007/s00228-009-0779-4
- By:
- Publication type:
- Article
Targeting the arginine metabolic brake enhances immunotherapy for leukaemia.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 8, p. 2201, doi. 10.1002/ijc.32028
- By:
- Publication type:
- Article
MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 203, p. 1, doi. 10.1126/scitranslmed.3006061
- By:
- Publication type:
- Article
Bone Marrow Lymphocytes of the Rat as Studied by Autoradiography.
- Published in:
- Acta Haematologica, 1965, v. 33, n. 1, p. 19, doi. 10.1159/000209510
- By:
- Publication type:
- Article
Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA‐matched allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 282, doi. 10.1002/ajh.25714
- By:
- Publication type:
- Article
Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. 1236, doi. 10.1002/ajh.25231
- By:
- Publication type:
- Article
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 789, doi. 10.1002/ajh.24771
- By:
- Publication type:
- Article
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0314-x
- By:
- Publication type:
- Article
The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years--a report from the EBMT acute leukemia working party.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0295-9
- By:
- Publication type:
- Article
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 6, p. 855, doi. 10.1002/cncr.28498
- By:
- Publication type:
- Article
Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 2, p. 244, doi. 10.1111/j.1365-2141.2011.08615.x
- By:
- Publication type:
- Article
Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 6, p. 887, doi. 10.1111/j.1365-2141.2008.07572.x
- By:
- Publication type:
- Article
Elevated FOSB-expression; a potential marker of valproate sensitivity in AML.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 3, p. 332, doi. 10.1111/j.1365-2141.2008.07449.x
- By:
- Publication type:
- Article
Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Biology and management of relapsed acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2005, v. 129, n. 1, p. 18, doi. 10.1111/j.1365-2141.2004.05318.x
- By:
- Publication type:
- Article
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse.
- Published in:
- British Journal of Haematology, 2001, v. 115, n. 3, p. 569, doi. 10.1046/j.1365-2141.2001.03155.x
- By:
- Publication type:
- Article
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 377, doi. 10.1634/theoncologist.2015-0314
- By:
- Publication type:
- Article
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2642, doi. 10.1002/cncr.35308
- By:
- Publication type:
- Article
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 15, p. 2922, doi. 10.1002/cncr.34268
- By:
- Publication type:
- Article
Heterogeneous genetic and non‐genetic mechanisms contribute to response and resistance to azacitidine monotherapy.
- Published in:
- EJHaem, 2022, v. 3, n. 3, p. 794, doi. 10.1002/jha2.527
- By:
- Publication type:
- Article
Estimation of current leukaemia-free survival following donor lymphocyte infusion therapy for patients with leukaemia who relapse after allografting: application of a multistate model.
- Published in:
- 2000
- By:
- Publication type:
- journal article